Hup A was initially identified as an inhibitor of acetylcholinesterase (AChE) based on Chinese databases, and it has been utilized in the treatment of cognitive disorders related to memory deficits, including Alzheimer’s disease and other types of dementia (Damar et al., 2016). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.